Successful Medicare Contractor Meeting
The experts unanimously endorsed Medicare coverage for EsoGuard, marking a final step towards near-term Medicare coverage for the test.
Lucid's Strong Financial Position
Lucid Diagnostics raised just under $27 million in an underwritten public offering, providing a sufficient runway through 2026.
Veris Commercial Partnership with OSU
Launched the commercial phase of the strategic partnership with OSU, targeting 1,000 patients in the first year.
Advancement of Implantable Device
Development work for the Veris implantable device is progressing well, with FDA submission planned for 2026.
Endoscopic Imaging Technology Licensing
Finalizing a license agreement for an Endoscopic Imaging Technology with Duke University and UNC.